
At Financial News Daily, every article is written by a human. We use AI only to assist with editing and quality checks, never to generate news. The journalism and editorial responsibility remain human. Happy reading!
I came across an article on Moneyweb this week about medical aid contribution increases. I’ll put the link at the end of this article because it’s a fairly comprehensive look at the increases across the various medical schemes in South Africa.
What interested me almost as much as the article itself were the comments from readers. There were about 20 when I read it, possibly more by the time this is published. Many were emotional, but not excessively so. What came through was something rather more worrying: a sense of hopelessness among people who are paying substantial amounts every month for medical cover and increasingly feel they are getting a raw deal.
And it’s not difficult to understand why.
South Africa has a public healthcare system that is broken in many respects. There are hospitals and medical professionals who provide excellent treatment, but the waiting times can be extraordinary. If you want an idea of what patients sometimes have to endure, consider the experience of someone I know who recently suffered a minor stroke.
On the first day, after having their vital signs taken at hospital, they waited five hours to see a doctor. The following day, they waited another six hours to obtain the results of their blood tests.
These are actual waiting times, not figures I’ve plucked out of the air.
For many South Africans, the alternative is private healthcare, which means paying for medical aid or medical insurance. But even here, there are no guarantees. A hospital plan, for example, is not necessarily going to provide the cover people assume it does. Some medical plans have significant exclusions, including restrictions on cover for strokes.
So people find themselves caught between an overstretched public healthcare system and a private healthcare industry that seems to become more expensive every year.
The reader comments on Moneyweb reflect this frustration. There is a growing perception that medical schemes have become enormously profitable businesses, with their executives enjoying increasingly generous remuneration while members face annual contribution increases that can reach 10%.
Doctors, meanwhile, are reportedly receiving increases of around 4% or less.
It raises some uncomfortable questions about where the money is going, how medical schemes manage their reserves and operating costs, and whether members are getting value for what they pay.
There is also the question of executive remuneration. The CEOs of these organisations have become extraordinarily wealthy, operating in a market where consumers have limited alternatives. When the public healthcare system is unable to provide reliable services, private medical schemes enjoy a captive market of people who feel they have little choice but to pay.
And there appears to be no end to this cycle. Another year, another increase, another squeeze on household finances.
One reader suggested an interesting alternative: why not buy shares in Discovery, for example, and use the dividends to pay for your medical aid contributions?
It sounds clever until you do the arithmetic. Using an annual dividend of approximately R3.84 per Discovery share and a three-member Essential Delta Core medical scheme costing around R69,300 a year, you would need approximately 18,000 shares. At a share price of R270, that’s close to R4.9 million invested.
And that’s before dividends tax, future medical aid increases or any reduction in the dividend. In other words, it’s an interesting investment idea for someone who already has several million rand to spare, but hardly a practical solution for the average medical aid member.
The comments on Moneyweb are worth reading because they reflect something much bigger than dissatisfaction with annual increases. They represent a growing protest about the affordability of private healthcare in South Africa.
People want greater transparency about costs and reserves. They want some restraint in executive remuneration, fairer treatment when claims are submitted, and proper protection for older members and those with chronic illnesses. Above all, they want contribution increases that bear some relationship to what ordinary households can actually afford.
I don’t think that’s asking too much.
All I can say is that it’s a terrible situation for people in South Africa, particularly those who have worked hard and saved in the expectation that they could afford decent medical cover when they needed it.
To be hammered with substantial increases year after year, simply to retain access to private healthcare, is becoming increasingly difficult to justify. Medical aid has become one of the biggest expenses in many household budgets, sometimes the biggest after accommodation.
This tells us something about the country we live in.
We have a public healthcare system that too often fails the people who depend on it, and a private healthcare industry that appears perfectly comfortable charging those who can afford an alternative increasingly exorbitant prices.
Between the two, the ordinary South African is left carrying the bill.
It’s difficult to escape the conclusion that, whether in the public or private sector, the interests of the patient and the paying customer have become secondary to everything else.
Editorial Disclosure & Disclaimer
Financial News Daily is an independent business news syndicate and a wholly owned subsidiary of Idea Accelerator. We publish financial, environmental and corporate commentary for digital platforms, media outlets and organisations.
Financial News Daily is committed to factual accuracy, fairness and responsible reporting. We take reasonable steps to verify information before publication. If you believe an article contains a factual error or inaccuracy, please contact us. We will investigate the matter and, where necessary, make appropriate corrections.
Nothing published here constitutes investment, legal or financial advice. All opinions are editorial commentary on matters of public and economic interest.
